Metal–organic framework and doxorubicin co-encapsulated pH-responsive hydrogels for synergistic breast cancer therapy
New Journal of Chemistry · 2026 · 50 (27) · 11169-11177
DOI: 10.1039/d6nj01310d ↗Kurz gefasst
Fachartikel in der Zeitschrift New Journal of Chemistry, 2026. Verfasst von Liezhi Cao und 4 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Hainan Medical University.
Abstract (Originalsprache)
Fe-MOF is synthesized and co-encapsulated with doxorubicin in pH-responsive hydrogels for chemotherapy, chemodynamic therapy and photodynamic therapy of breast cancer.
Förderung
- Hainan Medical University
Zitieren
APA
Cao, L., Gao, Q., Zuo, X., Kong, Y., & Chen, H. (2026). Metal–organic framework and doxorubicin co-encapsulated pH-responsive hydrogels for synergistic breast cancer therapy. New Journal of Chemistry, 50(27), 11169-11177. https://doi.org/10.1039/d6nj01310d
Vancouver
Cao L, Gao Q, Zuo X, Kong Y, Chen H. Metal–organic framework and doxorubicin co-encapsulated pH-responsive hydrogels for synergistic breast cancer therapy. New Journal of Chemistry. 2026;50(27):11169-11177. doi:10.1039/d6nj01310d
BibTeX
@article{Cao2026,
author = {Cao, Liezhi and Gao, Qiang and Zuo, Xiaoming and Kong, Yong and Chen, Haiying},
title = {Metal–organic framework and doxorubicin co-encapsulated pH-responsive hydrogels for synergistic breast cancer therapy},
journal = {New Journal of Chemistry},
year = {2026},
volume = {50},
number = {27},
pages = {11169--11177},
doi = {10.1039/d6nj01310d}
}
EUVIMED